| Inception | September 2024  |
|---|
Blindsight is an experimental medical device developed by Neuralink. [1] [2] It has received Breakthrough Device Designation from the US Food and Drugs Administration (FDA). [3] [4]
| Inception | September 2024 |
|---|
Blindsight is an experimental medical device developed by Neuralink. [1] [2] It has received Breakthrough Device Designation from the US Food and Drugs Administration (FDA). [3] [4]
Blindsight is being developed to enable individuals with total visual impairment due to damage to the optic nerve but with intact visual cortex to see, this is made possible by bypassing the optic nerve and directly stimulating the visual cortex to create a visual perception. [5] [6]
Blindsight is the ability of people who are cortically blind to respond to visual stimuli that they do not consciously see due to lesions in the primary visual cortex, also known as the striate cortex or Brodmann Area 17. The term was coined by Lawrence Weiskrantz and his colleagues in a paper published in a 1974 issue of Brain. A previous paper studying the discriminatory capacity of a cortically blind patient was published in Nature in 1973. The assumed existence of blindsight is controversial, with some arguing that it is merely degraded conscious vision.
The visual system is the physiological basis of visual perception. The system detects, transduces and interprets information concerning light within the visible range to construct an image and build a mental model of the surrounding environment. The visual system is associated with the eye and functionally divided into the optical system and the neural system.
In neuroanatomy, the lateral geniculate nucleus is a structure in the thalamus and a key component of the mammalian visual pathway. It is a small, ovoid, ventral projection of the thalamus where the thalamus connects with the optic nerve. There are two LGNs, one on the left and another on the right side of the thalamus. In humans, both LGNs have six layers of neurons alternating with optic fibers.
Elon Reeve Musk is a businessman and investor known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. Other involvements include ownership of X Corp., the company that operates the social media platform X, and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI. He is one of the wealthiest individuals in the world; as of August 2024 Forbes estimates his net worth to be US$247 billion.
Brain implants, often referred to as neural implants, are technological devices that connect directly to a biological subject's brain – usually placed on the surface of the brain, or attached to the brain's cortex. A common purpose of modern brain implants and the focus of much current research is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. This includes sensory substitution, e.g., in vision. Other brain implants are used in animal experiments simply to record brain activity for scientific reasons. Some brain implants involve creating interfaces between neural systems and computer chips. This work is part of a wider research field called brain–computer interfaces.
Neuroprosthetics is a discipline related to neuroscience and biomedical engineering concerned with developing neural prostheses. They are sometimes contrasted with a brain–computer interface, which connects the brain to a computer rather than a device meant to replace missing biological functionality.
Neurohacking is a subclass of biohacking, focused specifically on the brain. Neurohackers seek to better themselves or others by “hacking the brain” to improve reflexes, learn faster, or treat psychological disorders. The modern neurohacking movement has been around since the 1980s. However, herbal supplements have been used to increase brain function for hundreds of years. After a brief period marked by a lack of research in the area, neurohacking started regaining interest in the early 2000s. Currently, most neurohacking is performed via do-it-yourself (DIY) methods by in-home users.
A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD). Retinal implants are being developed by a number of private companies and research institutions, and three types are in clinical trials: epiretinal, subretinal, and suprachoroidal. The implants introduce visual information into the retina by electrically stimulating the surviving retinal neurons. So far, elicited percepts had rather low resolution, and may be suitable for light perception and recognition of simple objects.
BrainPort is a technology whereby sensory information can be sent to one's brain through an electrode array which sits atop the tongue. It was initially developed by Paul Bach-y-Rita as an aid to people's sense of balance, particularly of stroke victims. Bach-y-Rita founded Wicab in 1998.
A visual prosthesis, often referred to as a bionic eye, is an experimental visual device intended to restore functional vision in those with partial or total blindness. Many devices have been developed, usually modeled on the cochlear implant or bionic ear devices, a type of neural prosthesis in use since the mid-1980s. The idea of using electrical current to provide sight dates back to the 18th century, discussed by Benjamin Franklin, Tiberius Cavallo, and Charles LeRoy.
A human microchip implant is any electronic device implanted subcutaneously (subdermally) usually via an injection. Examples include an identifying integrated circuit RFID device encased in silicate glass which is implanted in the body of a human being. This type of subdermal implant usually contains a unique ID number that can be linked to information contained in an external database, such as identity document, criminal record, medical history, medications, address book, and other potential uses.
Neurostimulation is the purposeful modulation of the nervous system's activity using invasive or non-invasive means. Neurostimulation usually refers to the electromagnetic approaches to neuromodulation.
Stentrode is a small stent-mounted electrode array permanently implanted into a blood vessel in the brain, without the need for open brain surgery. It is in clinical trials as a brain–computer interface (BCI) for people with paralyzed or missing limbs, who will use their neural signals or thoughts to control external devices, which currently include computer operating systems. The device may ultimately be used to control powered exoskeletons, robotic prosthesis, computers or other devices.
A cortical implant is a subset of neuroprosthetics that is in direct connection with the cerebral cortex of the brain. By directly interfacing with different regions of the cortex, the cortical implant can provide stimulation to an immediate area and provide different benefits, depending on its design and placement. A typical cortical implant is an implantable microelectrode array, which is a small device through which a neural signal can be received or transmitted.
Neuralink Corp. is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs). It was founded by Elon Musk and a team of seven scientists and engineers. Neuralink was launched in 2016 and was first publicly reported in March 2017. The company is based in Fremont, California with plans to build a three-story building with office and manufacturing space near Austin, Texas in Del Valle, located about 10 miles east of Tesla's headquarters and manufacturing plant that opened in 2022.
Shivon Alice Zilis is a Canadian technology executive and venture capitalist.
Precision Neuroscience is an American brain–computer interface (BCI) company based in New York City and with offices in Mountain View, California, Addison, Texas and Minneapolis, Minnesota.
Noland Arbaugh is an American quadriplegic known for being the first human recipient of Neuralink's brain-computer interface (BCI) implant. He gained attention for his use of the device to regain digital autonomy after a spinal cord injury left him paralyzed.
Premia Spine TOPS System is an FDA-approved mechanical implant that serves as an alternative to lumbar interbody fusion surgery after decompression. It was developed by Impliant and commercially launched by Premia Spine.
Paradromics is an American brain–computer interface (BCI) company headquartered in Austin, Texas with a second office located in Oakland, California.
 | This article related to medical equipment is a stub. You can help Wikipedia by expanding it. |